Abstract
Until recently, the problem of resistance to antiviral drugs has been more potential than real. Although individual reports of resistant viruses have appeared, such isolates have been rare and usually of low virulence. The articles by Erlich et al.1 and Erice et al.2 in this issue of the Journal, as well as reports published elsewhere,3 , 4 indicate that the situation has changed dramatically. Progressive disease due to acyclovir-resistant herpes simplex virus and to ganciclovir-resistant cytomegalovirus in patients with the acquired immunodeficiency syndrome (AIDS) or who are otherwise immunocompromised is now a reality with important ramifications. Resistance of herpes simplex virus . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
